The Role of Chlamydia trachomatis Polymorphic Membrane Proteins in Inflammation and Sequelae among Women with Pelvic Inflammatory Disease
Table 1
Baseline characteristics of women by Pmp antibody expression.
Characteristics
PmpA
PmpD
PmpI
No
Yes
value
No
Yes
value
No
Yes
value
Demographics
Age
<25 years
30 (85.7)
4 (80.0)
0.7378
8 (80.0)
26 (86.7)
0.3213
8 (80.0)
26 (86.7)
0.3213
Race/ethnicity African American
27 (77.1)
4 (80.0)
0.8862
8 (80.0)
26 (76.7)
0.3350
8 (80.0)
23 (76.7)
0.3350
Married
4 (12.1)
1 (20.0)
0.6272
1 (10.0)
4 (14.3)
0.4079
1 (10.0)
4 (14.3)
0.4079
Uninsured
11 (33.3)
3 (60.0)
0.0876
6 (60.0)
18 (64.3)
0.2850
6 (60.0)
18 (64.3)
0.2850
Education less than high school
14 (40.0)
2 (40.0)
1.000
2 (20.0)
14 (87.5)
0.1091
2 (20.0)
14 (46.7)
0.1091
Clinical
Neisseria gonorrhoeae
8 (25.8)
2 (50.0)
0.3134
3 (37.5)
7 (25.9)
0.2709
2 (22.2)
8(30.8)
0.3064
Mycoplasma genitalium
3 (12.5)
1 (25.0)
0.3954
1 (25.0)
3 (12.5)
0.3954
1 (16.7)
3 (13.6)
0.4513
Bacterial vaginosis
21 (67.7)
1 (20.0)
0.0584
5 (55.6)
17 (62.9)
0.2800
5 (55.6)
17 (63.0)
0.2800
History of PID
10 (28.6)
1 (20.0)
0.3970
4 (40.0)
7 (23.3)
0.1849
3 (30.0)
8 (26.7)
0.3038
History of chlamydia
15 (45.5)
3 (60.0)
0.3089
4 (44.4)
14 (48.3)
0.7183
5 (55.6)
13 (44.8)
0.4272
aPelvic pain (mean score ± SD)
65 ± 22
75 ± 15
0.3605
69 ± 14
66 ± 23
0.7387
65 ± 16
67 ± 17
0.7810
bDays of pain(mean score ± SD)
8 ± 7
5 ± 2
0.3238
6 ± 6
9 ± 7
0.3637
7 ± 7
8 ± 7
0.7569
Behavior
Current smoker
15 (42.9)
4 (80.0)
0.1237
4 (40.0)
5 (50.0)
0.2481
2 (20.0)
17 (56.7)
0.0411
Drug use
12 (34.3)
2 (40.0)
0.3596
4 (40.0)
10 (33.3)
0.2719
4 (40.0)
10 (33.3)
0.2719
a( mean of current pelvic pain score, average pelvic pain score and worst pelvic pain score) × 10; bSelf-reported time to treatment following onset of symptoms.
